Home Trials Current Trials ESCAPE NA-1: Extension of Stroke Care by Added neuroProtection to Endovascular treatment

ESCAPE NA-1: Extension of Stroke Care by Added neuroProtection to Endovascular treatment

E-mail Print PDF

Lead PI: Professor Michael D Hill and Dr Mayank Goyal

Status: Recruiting

No. of Patients Currently Recruited: 143                                No. of Patients Required: 1120

ESCAPE-NA1 is examining the rapid addition of single dose NA-1 to the treatment of acute ischemic stroke patients with large vessel occlusion undergoing endovascular thrombectomy.  Patients are randomized 1:1 to study drug (active drug or saline placebo) and then followed for 90 days.  The primary outcome is disability measured on the modified Rankin Scale at 90 days.  Up to 1120 patients will be recruited from centres in Canada, US, Europe/UK, South Korea and Australia.

Trial URL:

www.escapena1.ca

https://clinicaltrials.gov/ct2/show/NCT02930018?cond=escape-na1&rank=1

NCT02930018

Last Updated ( Tuesday, 23 January 2018 13:17 )  


ASTN Latest news

Top Views